Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Every word you type has to appear somewhere in the question, and the closest matches are ranked first.
15,213 questions in 2,394 reviews
current versionsNo studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
IVIg vs SCIg Adverse events · people with multifocal motor neuropathy Immunoglobulin for multifocal motor neuropathy (2022) · Cochrane | no estimate extracted | NR | No studies |
IVIg vs placebo Proportion of participants with an improvement in disability at 12 months or later · people with multifocal motor neuropathy Immunoglobulin for multifocal motor neuropathy (2022) · Cochrane | no estimate extracted | NR | No studies |
IVIg vs placebo Maintenance · people with multifocal motor neuropathy Immunoglobulin for multifocal motor neuropathy (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Primary outcomes · patients with stroke Antiepileptic drugs for the primary and secondary prevention of seizures after stroke (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Secondary seizure prophylaxis after stroke · patients with stroke Antiepileptic drugs for the primary and secondary prevention of seizures after stroke (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Secondary outcomes · patients with stroke Antiepileptic drugs for the primary and secondary prevention of seizures after stroke (2022) · Cochrane | no estimate extracted | NR | No studies |
Homeopathic medicinal products vs placebo or usual care Recurrence of ARTI · children aged up to 16 years with ARTIs Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children (2022) · Cochrane | no estimate extracted | NR | No studies |
Homeopathic medicinal products vs placebo or usual care Days off work for parents · children aged up to 16 years with ARTIs Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children (2022) · Cochrane | no estimate extracted | NR | No studies |
Homeopathic medicinal products vs placebo or usual care Need for antibiotics · children aged up to 16 years with ARTIs Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children (2022) · Cochrane | no estimate extracted | NR | No studies |
Homeopathic medicinal products (non‐individualised treatment) vs placebo or usual care Disease severity · children aged up to 16 years with ARTIs Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children (2022) · Cochrane | no estimate extracted | NR | No studies |
Homeopathic medicinal products (non‐individualised treatment) vs placebo or usual care Days off work for parents · children aged up to 16 years with ARTIs Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children (2022) · Cochrane | no estimate extracted | NR | No studies |
Homeopathic medicinal products (non‐individualised treatment) vs placebo or usual care Need for antibiotics · children aged up to 16 years with ARTIs Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children (2022) · Cochrane | no estimate extracted | NR | No studies |
Interventions (vitamin B1, mefenamic acid, tranexamic acid) vs placebo or active comparators (desmopressin, sodium diclofenac, flavonoids) Interventions versus comparisons Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use (2022) · Cochrane | no estimate extracted | NR | No studies |
Ulipristal acetate vs placebo Interventions vs comparisons Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use (2022) · Cochrane | no estimate extracted | NR | No studies |
Mefanamic acid vs Vitex agnus Interventions vs comparisons Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use (2022) · Cochrane | no estimate extracted | NR | No studies |
Mefanamic acid vs Vitex agnus Menstrual blood loss PBAC score Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use (2022) · Cochrane | no estimate extracted | NR | No studies |
Naproxen vs placebo Naproxen vs placebo Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use (2022) · Cochrane | no estimate extracted | NR | No studies |
Interventions (ibuprofen, tolfenamic acid, aspirin, tranexamic acid) vs placebo or active comparators (paracetamol, tranexamic acid) Ibuprofen vs placebo Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use (2022) · Cochrane | no estimate extracted | NR | No studies |
Interventions (ibuprofen, tolfenamic acid, aspirin, tranexamic acid) vs placebo or active comparators (paracetamol, tranexamic acid) Aspirin vs paracetamol Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use (2022) · Cochrane | no estimate extracted | NR | No studies |
Interventions (ibuprofen, tolfenamic acid, aspirin, tranexamic acid) vs placebo or active comparators (paracetamol, tranexamic acid) Adverse events or side effects Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use (2022) · Cochrane | no estimate extracted | NR | No studies |
Interventions (ibuprofen, tolfenamic acid, aspirin, tranexamic acid) vs placebo or active comparators (paracetamol, tranexamic acid) Menstrual blood loss % occurrence of heavy menstrual bleeding (alkaline hematin method) Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use (2022) · Cochrane | no estimate extracted | NR | No studies |
Interventions (ibuprofen, tolfenamic acid, aspirin, tranexamic acid) vs placebo or active comparators (paracetamol, tranexamic acid) Menstrual blood loss % occurrence heavy menstrual bleeding (PBAC score) Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse events or side effects Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Menstrual blood loss Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Mifepristone vs vitamin B Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Naproxen vs estradiol Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use (2022) · Cochrane | no estimate extracted | NR | No studies |
Interventions (vitamin B1, mefenamic acid, tranexamic acid) vs placebo or active comparators (desmopressin, sodium diclofenac, flavonoids) Adverse events or side effects Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use (2022) · Cochrane | no estimate extracted | NR | No studies |
Interventions (ibuprofen, tolfenamic acid) vs placebo Ibuprofen vs placebo Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use (2022) · Cochrane | no estimate extracted | NR | No studies |
Prefabricated foot orthoses vs shoes Quality of life · children with asymptomatic flat feet Foot orthoses for treating paediatric flat feet (2022) · Cochrane | no estimate extracted | NR | No studies |
Prefabricated foot orthoses vs shoes Treatment success · children with asymptomatic flat feet Foot orthoses for treating paediatric flat feet (2022) · Cochrane | no estimate extracted | NR | No studies |
Prefabricated foot orthoses vs shoes Adverse events · children with asymptomatic flat feet Foot orthoses for treating paediatric flat feet (2022) · Cochrane | no estimate extracted | NR | No studies |
Prefabricated foot orthoses vs shoes Serious adverse events · children with asymptomatic flat feet Foot orthoses for treating paediatric flat feet (2022) · Cochrane | no estimate extracted | NR | No studies |
Custom foot orthoses vs prefabricated foot orthoses Function or disability · children with asymptomatic flat feet Foot orthoses for treating paediatric flat feet (2022) · Cochrane | no estimate extracted | NR | No studies |
Custom foot orthoses vs prefabricated foot orthoses Quality of life · children with asymptomatic flat feet Foot orthoses for treating paediatric flat feet (2022) · Cochrane | no estimate extracted | NR | No studies |
Custom foot orthoses vs prefabricated foot orthoses Treatment success · children with asymptomatic flat feet Foot orthoses for treating paediatric flat feet (2022) · Cochrane | no estimate extracted | NR | No studies |
Customised foot orthoses vs shoes Function or disability · children with asymptomatic flat feet Foot orthoses for treating paediatric flat feet (2022) · Cochrane | no estimate extracted | NR | No studies |
Custom foot orthoses vs prefabricated foot orthoses Adverse events · children with asymptomatic flat feet Foot orthoses for treating paediatric flat feet (2022) · Cochrane | no estimate extracted | NR | No studies |
Custom foot orthoses vs prefabricated foot orthoses Serious adverse events · children with asymptomatic flat feet Foot orthoses for treating paediatric flat feet (2022) · Cochrane | no estimate extracted | NR | No studies |
Custom foot orthoses vs shoes Adverse events · children with juvenile idiopathic arthritis (JIA) and flat feet Foot orthoses for treating paediatric flat feet (2022) · Cochrane | no estimate extracted | NR | No studies |
Custom foot orthoses vs shoes Serious adverse events · children with juvenile idiopathic arthritis (JIA) and flat feet Foot orthoses for treating paediatric flat feet (2022) · Cochrane | no estimate extracted | NR | No studies |
Customised foot orthoses vs shoes Quality of life · children with asymptomatic flat feet Foot orthoses for treating paediatric flat feet (2022) · Cochrane | no estimate extracted | NR | No studies |
Prefabricated foot orthoses vs shoes Adverse events · children with juvenile idiopathic arthritis and flat feet Foot orthoses for treating paediatric flat feet (2022) · Cochrane | no estimate extracted | NR | No studies |
Prefabricated foot orthoses vs shoes Serious adverse events · children with juvenile idiopathic arthritis and flat feet Foot orthoses for treating paediatric flat feet (2022) · Cochrane | no estimate extracted | NR | No studies |
Customised foot orthoses vs shoes Treatment success · children with asymptomatic flat feet Foot orthoses for treating paediatric flat feet (2022) · Cochrane | no estimate extracted | NR | No studies |
Custom foot orthoses vs prefabricated foot orthoses Adverse effects · children with juvenile idiopathic arthritis and flat feet Foot orthoses for treating paediatric flat feet (2022) · Cochrane | no estimate extracted | NR | No studies |
Custom foot orthoses vs prefabricated foot orthoses Serious adverse events · children with juvenile idiopathic arthritis and flat feet Foot orthoses for treating paediatric flat feet (2022) · Cochrane | no estimate extracted | NR | No studies |
Prefabricated foot orthoses vs shoes Pain · children with symptomatic flat feet Foot orthoses for treating paediatric flat feet (2022) · Cochrane | no estimate extracted | NR | No studies |
Prefabricated foot orthoses vs shoes Treatment success · children with symptomatic flat feet Foot orthoses for treating paediatric flat feet (2022) · Cochrane | no estimate extracted | NR | No studies |
Prefabricated foot orthoses vs shoes Withdrawal due to adverse events · children with symptomatic flat feet Foot orthoses for treating paediatric flat feet (2022) · Cochrane | no estimate extracted | NR | No studies |
Prefabricated foot orthoses vs shoes Adverse effects · children with symptomatic flat feet Foot orthoses for treating paediatric flat feet (2022) · Cochrane | no estimate extracted | NR | No studies |